- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Florida Cancer Specialists & Research Institute Breast Cancer Partnership Receives National Accreditation
Collaboration with community partners recognized for patient care excellence.
Davenport, Florida — Florida Cancer Specialists & Research Institute (FCS), in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has received a 3-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.
The breast cancer program received this designation for meeting national standards of excellence for providing comprehensive, patient-centered, multidisciplinary care and demonstrating high-quality clinical outcomes for patients with breast disease.
FCS medical oncologist Swati Pathak, MD said, “We value our partnership with our colleagues to ensure that patients throughout our community have access to a comprehensive range of exceptional care and treatment for breast cancer and other diseases of the breast.”
“This accreditation confirms that our patients consistently receive the highest quality of care, which results in outstanding clinical outcomes,” added Wasif Riaz, MD, FCS medical oncologist. “We are extremely proud.”
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
